Astellas Pharma announces US FDA listing of DIGITIVA for the …
网页7 小时之前 · Tokyo. Friday, September 20, 2024, 11:00 Hrs [IST] Astellas Pharma Inc. announced that DIGITIVA, a non-invasive digital health solution for heart failure management, has been listed with the US Food and Drug Administration (FDA). DIGITIVA is classified as a Class I Software as a Medical Device (SaMD) and is exempt from 510 (k) premarket submission.
Neuberg Diagnostics launches personalized genomics platform, …
网页6 小时之前 · Our Bureau, Mumbai. Friday, September 20, 2024, 12:30 Hrs [IST] Neuberg Diagnostics, a global leader in cutting-edge healthcare diagnostics, has officially launched its groundbreaking personalized genomics platform, “Geniee-Decode your DNA”. The launch signifies a monumental shift in the future of personalized healthcare, positioning ...
JB Pharma accelerates global expansion and diversifies into …
网页1 天前 · JB Pharma has announced significant strides in its strategic growth, diversifying into progressive therapies while strengthening its presence in international markets. Over the past three years, the company has seen robust growth, with revenue increasing at a 19% compound annual growth rate (CAGR ...
Takeda commits over US$ 32 million in five new global CSR …
网页8 小时之前 · Takeda, a company is focused on creating better health for people and a brighter future for the world, committed JPY4.6 billion (Approx. USD 32 million) to five new Global Corporate Social Responsibility (CSR) partners as part of the company’s ongoing commitment to improving health systems ...
Pfizer, BioNTech receive US FDA approval & authorization for …
网页Saturday, August 24, 2024, 09:00 Hrs [IST] Pfizer Inc. and BioNTech SE announced that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application for individuals 12 years of age and older (COMIRNATY (Covid-19 Vaccine, mRNA), and granted emergency use authorization for individuals 6 months through 11 ...
PvPI and ADR monitoring & reporting should be made part of …
网页10 小时之前 · Peethaambaran Kunnathoor, Chennai Friday, September 20, 2024, 08:00 Hrs [IST] Since the Pharmacovigilance Programme of India (PvPI) is taking momentum in the health sector today, the PvPI and the Adverse Drug Reaction (ADR) monitoring and reporting should be made part of the curriculum of the pharmacy education.
Indian pharma sees US Biosecure Act to present a significant ...
网页2024年9月13日 · The US Biosecure Act will present a significant opportunity for Indian contract development and manufacturing organisations (CDMOs) to expand their market share, enhance capabilities, and contribute to the global pharmaceutical supply chain. However, the Act's final form and implementation will determine the exact impact on the Indian CDMOs.
News - Pharmabiz.com
网页2 天之前 · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing.
Indian pharmaceutical industry leads global market with record ...
网页2024年9月2日 · The Indian pharmaceutical industry is making headlines with its remarkable achievements in regulatory approvals and strategic growth plans, positioning itself as a key player on the global stage, said K Raja Bhanu, director general of the Pharmaceuticals Export Promotion Council of India (Pharmexcil ...
Pharmaceuticals export reports 8.4 per cent growth in July
网页2024年8月20日 · Pharmaceuticals export reports 8.4 per cent growth in July. Exports of drugs and pharmaceuticals from the country registered 8.36 per cent growth, while imports reported a marginal increase during the month of July, 2024. In Rupee terms, the growth in imports was over 10 per cent during the month, according to official data.
跳至内容